Evidence map›Paper›PMID 27351564›Full record

ReviewWorld journal of pediatrics : WJP2016

An epigenetic view of developmental diseases: new targets, new therapies.

Pei Xie, Li-Qun Zang, Xue-Kun Li, Qiang Shu

Abstract readReview
PubMed Publisher
In one paragraph

Review in World journal of pediatrics : WJP, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
1.4field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 25 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
  4. Article
  5. Article
  6. Epigenetics and Congenital Heart Diseases.Journal of cardiovascular development and disease · 2022
    Review
  7. Review
  8. Review
  9. Article
  10. Review
  11. DNA Methylation Associated with Mitochondrial Dysfunction in a South African Autism Spectrum Disorder Cohort.Autism research : official journal of the International Society for Autism Research · 2020
    Article
  12. The roles of DNA, RNA and histone methylation in ageing and cancer.Nature reviews. Molecular cell biology · 2019
    Review
  13. Article
  14. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 1 country.

Pei XieInstitute of Genetics, College of Life Sciences, Zhejiang University, Hangzhou, China.
Li-Qun ZangChildren's Hospital, Zhejiang University School of Medicine, Hangzhou, China.
Xue-Kun LiChildren's Hospital, Zhejiang University School of Medicine, Hangzhou, China.
Qiang ShuChildren's Hospital, Zhejiang University School of Medicine, Hangzhou, China. shuqiang@zju.edu.cn.
Children's Hospital of Zhejiang University · CNZhejiang University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundFunction of epigenetic modifications is one of the most competitive fields in life science. Over the past several decades, it has been revealed that epigenetic modifications play essential roles in development and diseases including developmental diseases. In the present review, we summarize the recent progress about the function of epigenetic regulation, especially DNA and RNA modifications in developmental diseases. DATA SOURCES: Original research articles and literature reviews published in PubMed-indexed journals.

resultsDNA modifications including methylation and demethylation can regulate gene expression, and are involved in development and multiple diseases including Rett syndrome, Autism spectrum disorders, congenital heart disease and cancer, etc. RNA methylation and demethylation play important roles in RNA processing, reprogramming, circadian, and neuronal activity, and then modulate development.

conclusionsDNA and RNA modifications play important roles in development and diseases through regulating gene expression. Epigenetic components could serve as novel targets for the treatment of developmental diseases.

Indexed as

DNA MethylationEpigenesis, GeneticAutism Spectrum DisorderChild, PreschoolDevelopmental DisabilitiesFemaleForecastingGenetic TherapyHeart Defects, CongenitalHumansInfantInfant, NewbornMaleRNARNA5-hydroxymethylcytosinecongenital heart diseasedevelopmentDNA modificationneurological disordersRNA modification

Identifiers

PMID27351564
OpenAlexW2470808398

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.